Life Sciences

The closure is part of the company’s overall strategic consolidation plan, known as Project Viking, which will cost the company about $4 million in restructuring expenses.

Two new startups have arrived at Massachusetts Biomedical Initiatives, the Worcester-based life sciences incubator steadily increasing its footprint throughout Central Massachusetts.

WBJ’s Best of Business awards features the organizations to best help your companies succeed.

Rentschler Biopharma, a Germany-based biopharmaceuticals manufacturer with a facility in Milford, is set to produce a novel blood coagulation treatment developed by Netherlands-based VarmX, with the hopes to support future commercialization.

The year-long battle over National Institutes of Health funding, which caused UMass Chan Medical School to lay off employees in April, reached a new milestone on Tuesday.

CCC was not placed into receivership, no hospital replaced Nashoba Valley Medical Center, and the results of eight other bold predictions for 2025.

As the use of GLP-1s, like Ozempic, has skyrocketed in the U.S., two researchers at UMass Chan Medical School in Worcester have received a $2 million award from the Centers for Disease Control and Prevention to study lifestyle change of those taking the popular drug.

The BOB awards recognize the best business-to-business companies in Central Massachusetts: those dedicated to excellence and delivering exceptional products.

Five Central Massachusetts life sciences companies are splitting $5 million in tax incentives to create 245 jobs in the region.

Nominees were evaluated independently by three volunteer judges, who scored each on their professional achievements, community contributions, and mentorship of young professionals.